These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4769561)

  • 1. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 2. Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man.
    Bachmayer H; Liehl E; Schmidt G
    Dev Biol Stand; 1975; 28():336-9. PubMed ID: 1126577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Postgrad Med J; 1973 Mar; 49(569):152-8. PubMed ID: 4802501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive influenza vaccination--possibilities and limits in the prevention of influenza-virus infections].
    Wesselius-de Casparis A
    Med Monatsschr; 1973 Oct; 27(10):447-9. PubMed ID: 4777787
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.
    Jennings R; Potter CW; McLaren C
    J Immunol; 1974 Dec; 113(6):1834-43. PubMed ID: 4547776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of immunogenicity and safety of domestic influenza vaccines].
    Yao J; Li Q; Xu Q; Feng CF; Lu YM; Xu BQ; Lu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):735. PubMed ID: 15555412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of influenza by vaccines administered intramuscularly and intradermally].
    Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC
    Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of complement fixation and haemagglutination inhibition tests in the diagnosis of influenza A.
    Pyhälä R; Kleemola M
    Acta Virol; 1976 Feb; 20(1):66-9. PubMed ID: 7943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killed subunit influenza vaccine in children.
    Phillips CF; Phillips CA; Hodgkin WE; Forsyth BR; Rubin BA; Geraghty ME
    Pediatrics; 1973 Sep; 52(3):416-9. PubMed ID: 4738294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 13. Purified influenza virus vaccine. A study of viral reactivity and antigenicity.
    Peck FB
    JAMA; 1968 Dec; 206(10):2277-82. PubMed ID: 5696082
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus.
    Masurel N; Baars AJ; Frankena H
    Antonie Van Leeuwenhoek; 1973; 39(3):461-71. PubMed ID: 4543055
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical and serologic comparison of standard and purified bivalent inactivated influenza vaccines.
    Finklea JF; Sandifer SH; Peck FB; Manos JP
    J Infect Dis; 1969 Dec; 120(6):708-12. PubMed ID: 4911903
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 18. [Live influenza vaccination of military personnel (author's transl)].
    Kunz C; Hofmann H; Carda K
    Wien Klin Wochenschr; 1978 Oct; 90(19):707-10. PubMed ID: 695667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody determination following influenza vaccination].
    Wegmann A
    Ther Umsch; 1972 Dec; 29(12):747-9. PubMed ID: 4639117
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.
    Potter CW; Jennings R; Marine WM; McLaren C
    Microbios; 1973; 8(30):101-10. PubMed ID: 4801251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.